MedTrace Logo

Brain MRI (Magnetic Resonance Imaging) Scans of Patients With Treatment Resistant Depression (TRD) and Healthy Controls

NCT01162434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2012-07-12

No results posted yet for this study

Summary

Treatment resistant depression (TRD) is a major health concern, with 10% of patients with major depressive disorder not responding to conventional treatments. The investigators propose to compare the MRI (magnetic resonance imaging) brain scans of patients with TRD, which were collected during surgical planning for deep brain stimulation, with age, sex, handedness and education-matched healthy volunteer controls, to investigate anatomical differences, specifically the volume of certain brain structures.

Conditions

  • Mental Disorders

Sponsors & Collaborators

  • North Bristol NHS Trust

    collaborator OTHER

  • University of Bristol

    lead OTHER

Principal Investigators

  • Andrea Malizia, MD · University of Bristol

Eligibility

Min Age
26 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01162434 on ClinicalTrials.gov